Key points from article :
Tempus has unveiled a breakthrough technology for oncologists, Tempus ONE.
Smart & portable device offers physicians real-time access to all the clinical insights & data contained in Tempus’ genomic reports.
Tempus’ multi-omic molecular tests arm oncologists with their patients’ actionable genetic alterations.
Company’s proprietary platform connects with electronic health records (EHR) to provide clinical context.
Handheld, cube-like device takes questions and input from physicians through an embedded microphone. Produces a response for playback through its proprietary voice-activated speaker system.
“..harnessing the almost 30 petabytes of data we have collected...embedded into a device..puts the full breadth and scope of our technology platform in the hands of every doctor we serve" - Eric Lefkofsky, CEO.
